No Data
No Data
Executive Reshuffles: CRM, SWKS, and APD
Express News | GoodRx Appoints Christopher a. Mcginnis as Chief Financial Officer
GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer
Morgan Stanley Maintains GoodRx(GDRX.US) With Hold Rating, Maintains Target Price $6
GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10